<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:ACRS (USA) Also Trade In: Germany UK

Aclaris Therapeutics Inc $ 1.65 0.04 (2.48%)

Volume:
812,418
Avg Vol (1m):
1,858,508
Market Cap $:
68.25 Mil
Enterprise Value $:
-16,350,000.00
P/E (TTM):
0.00
P/B:
0.54
Warning! GuruFocus has detected 4 Severe warning signs with ACRS. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

4.4/10
Current Vs Industry Vs History
Cash-To-Debt 3.74
Equity-to-Asset 0.63
Debt-to-Equity 0.23
Debt-to-EBITDA -0.23
N/A
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.82
DISTRESS
GREY
SAFE
Beneish M-Score 0.62
Not Manipulator
Manipulator
WACC vs ROIC
ROIC -305.48 %
WACC 5.63 %

Profitability

1/10
Current Vs Industry Vs History
Operating Margin % -861.63
Net Margin % -979.65
ROE % -92.81
ROA % -70.61
ROC (Joel Greenblatt) % -3272.47
3-Year EBITDA Growth Rate -6
3-Year EPS without NRI Growth Rate -2.1

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -17.7

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 1.01
Price-to-Median-PS-Value 0.06
Earnings Yield (Greenblatt) % 833.42